Cargando…
Modified-Chitosan/siRNA Nanoparticles Downregulate Cellular CDX2 Expression and Cross the Gastric Mucus Barrier
Development of effective non-viral vectors is of crucial importance in the implementation of RNA interference in clinical routine. The localized delivery of siRNAs to the gastrointestinal mucosa is highly desired but faces specific problems such as the stability in gastric acidity conditions and the...
Autores principales: | Sadio, Ana, Gustafsson, Jenny K., Pereira, Bruno, Gomes, Carla Pereira, Hansson, Gunnar C., David, Leonor, Pêgo, Ana Paula, Almeida, Raquel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055692/ https://www.ncbi.nlm.nih.gov/pubmed/24925340 http://dx.doi.org/10.1371/journal.pone.0099449 |
Ejemplares similares
-
Dynamics of SOX2 and CDX2 Expression in Barrett's Mucosa
por: Barros, Rita, et al.
Publicado: (2016) -
Engineering a Novel
Self-Assembled Multi-siRNA Nanocaged
Architecture with Controlled Enzyme-Mediated siRNA Release
por: Moreno, Pedro M. D., et al.
Publicado: (2022) -
Mucus Properties and Goblet Cell Quantification in Mouse, Rat and Human Ileal Peyer's Patches
por: Ermund, Anna, et al.
Publicado: (2013) -
Protection and Systemic Translocation of siRNA Following Oral Administration of Chitosan/siRNA Nanoparticles
por: Ballarín-González, Borja, et al.
Publicado: (2013) -
Chitosan and Its Structural Modifications for siRNA Delivery
por: Al-Absi, Mona Y., et al.
Publicado: (2023)